These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21785893)

  • 1. Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences.
    Li Q; Guo Y; Ou Q; Wu WJ; Chen N; Zhu X; Tan W; Yuan F; Dawn B; Luo L; Hunt GN; Bolli R
    Basic Res Cardiol; 2011 Nov; 106(6):1367-77. PubMed ID: 21785893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences.
    Li Q; Guo Y; Wu WJ; Ou Q; Zhu X; Tan W; Yuan F; Chen N; Dawn B; Luo L; O'Brien E; Bolli R
    Basic Res Cardiol; 2011 Nov; 106(6):1355-66. PubMed ID: 21779912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences.
    Li Q; Guo Y; Tan W; Stein AB; Dawn B; Wu WJ; Zhu X; Lu X; Xu X; Siddiqui T; Tiwari S; Bolli R
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H584-9. PubMed ID: 16172153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.
    Melo LG; Agrawal R; Zhang L; Rezvani M; Mangi AA; Ehsan A; Griese DP; Dell'Acqua G; Mann MJ; Oyama J; Yet SF; Layne MD; Perrella MA; Dzau VJ
    Circulation; 2002 Feb; 105(5):602-7. PubMed ID: 11827926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme Oxygenase-1 Gene Therapy Provides Cardioprotection Via Control of Post-Ischemic Inflammation: An Experimental Study in a Pre-Clinical Pig Model.
    Hinkel R; Lange P; Petersen B; Gottlieb E; Ng JK; Finger S; Horstkotte J; Lee S; Thormann M; Knorr M; El-Aouni C; Boekstegers P; Reichart B; Wenzel P; Niemann H; Kupatt C
    J Am Coll Cardiol; 2015 Jul; 66(2):154-65. PubMed ID: 26160631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway.
    Li Q; Guo Y; Ou Q; Cui C; Wu WJ; Tan W; Zhu X; Lanceta LB; Sanganalmath SK; Dawn B; Shinmura K; Rokosh GD; Wang S; Bolli R
    Circulation; 2009 Sep; 120(13):1222-30. PubMed ID: 19752329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function.
    Liu X; Pachori AS; Ward CA; Davis JP; Gnecchi M; Kong D; Zhang L; Murduck J; Yet SF; Perrella MA; Pratt RE; Dzau VJ; Melo LG
    FASEB J; 2006 Feb; 20(2):207-16. PubMed ID: 16449792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury.
    Squadrito F; Deodato B; Squadrito G; Seminara P; Passaniti M; Venuti FS; Giacca M; Minutoli L; Adamo EB; Bellomo M; Marini R; Galeano M; Marini H; Altavilla D
    Lab Invest; 2003 Aug; 83(8):1097-104. PubMed ID: 12920239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction.
    Liu X; Simpson JA; Brunt KR; Ward CA; Hall SR; Kinobe RT; Barrette V; Tse MY; Pang SC; Pachori AS; Dzau VJ; Ogunyankin KO; Melo LG
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H48-59. PubMed ID: 17322421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.
    Li Q; Guo Y; Xuan YT; Lowenstein CJ; Stevenson SC; Prabhu SD; Wu WJ; Zhu Y; Bolli R
    Circ Res; 2003 Apr; 92(7):741-8. PubMed ID: 12702642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury.
    Wojakowski W; Tendera M; Cybulski W; Zuba-Surma EK; Szade K; Florczyk U; Kozakowska M; Szymula A; Krzych L; Paslawska U; Paslawski R; Milewski K; Buszman PP; Nabialek E; Kuczmik W; Janiszewski A; Dziegiel P; Buszman PE; Józkowicz A; Dulak J
    Thromb Haemost; 2012 Sep; 108(3):464-75. PubMed ID: 22872040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.
    Li Q; Guo Y; Tan W; Ou Q; Wu WJ; Sturza D; Dawn B; Hunt G; Cui C; Bolli R
    Circulation; 2007 Oct; 116(14):1577-84. PubMed ID: 17785622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo.
    Tang YL; Qian K; Zhang YC; Shen L; Phillips MI
    J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):251-63. PubMed ID: 16382261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.
    Prasad KM; Smith RS; Xu Y; French BA
    J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
    Penumathsa SV; Koneru S; Zhan L; John S; Menon VP; Prasad K; Maulik N
    J Mol Cell Cardiol; 2008 Jan; 44(1):170-9. PubMed ID: 18001768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heme oxygenase-1 expression and activity on the heart function in ischemia-reperfusion].
    Kukoba TV; Kotsiuruba AV; Moĭbenko OO
    Fiziol Zh (1994); 2006; 52(1):41-8. PubMed ID: 16553297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction.
    Mohan IK; Khan M; Wisel S; Selvendiran K; Sridhar A; Carnes CA; Bognar B; Kálai T; Hideg K; Kuppusamy P
    Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H140-51. PubMed ID: 18978191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
    Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
    J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury.
    Galeano M; Deodato B; Altavilla D; Squadrito G; Seminara P; Marini H; Stagno d'Alcontres F; Colonna M; Calò M; Lo Cascio P; Torre V; Giacca M; Venuti FS; Squadrito F
    Crit Care Med; 2003 Apr; 31(4):1017-25. PubMed ID: 12682466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice.
    Liu X; Wei J; Peng DH; Layne MD; Yet SF
    Diabetes; 2005 Mar; 54(3):778-84. PubMed ID: 15734856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.